Multiple myeloma
Investigate the ability of ZnDDC to inhibit NFkB p65 and embryonic cancer stem cell markers (sox2, oct4 and nanog) in hypoxia cultured multiple myeloma cell lines using real-time PCR.
Investigate the ability of ZnDDC to inhibit NFkB p65 and embryonic cancer stem cell markers (sox2, oct4 and nanog) in hypoxia cultured multiple myeloma cell lines using real-time PCR.